Drug Trial Radar · NCT00672477
Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness
Last checked: Nov 19, 2026Latest source record: Mar 8, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
237
Actual
Start
Jun 2008
Primary completion
Feb 2013
Study completion Feb 2013
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Progenics Pharmaceuticals, Inc.
- First posted
- May 6, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and efficacy of methylnaltrexone administered as subcutaneous injections in subjects who have opioid-induced constipation and an advanced illness. The hypothesis is that methylnaltrexone will be safe and effective in relieving opioid-induced constipation in these subjects.
Conditions
- Opioid-Induced Constipation
Interventions
MethylnaltrexoneDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Proportion of Subjects Who Have a Rescue-free Laxation Response Within 4 Hours After at Least 2 of the First 4 DosesTime frame: 7 days
Locations
60 sites in 12 countries. Site status is shown where the registry gives one.
Salix Investigational Site
Mobile, Alabama
Salix Investigational Site
Laguna Hills, California
Salix Investigational Site
Lancaster, California
Salix Investigational Site
Aurora, Colorado
Salix Investigational Site
Auburndale, Florida
Salix Investigational Site
Hudson, Florida
Salix Investigational Site
Lakeland, Florida
Salix Investigational Site
Lakeland, Florida
Salix Investigational Site
Miami Springs, Florida
Salix Investigational Site
Ruskin, Florida
Salix Investigational Site
Sebring, Florida
Salix Investigational Site
Tampa, Florida
Salix Investigational Site
Tampa, Florida
Salix Investigational Site
Tampa, Florida
Salix Investigational Site
Temple Terrace, Florida
Salix Investigational Site
West Palm Beach, Florida
Salix Investigational Site
Orange, New Jersey
Salix Investigational Site
Albuquerque, New Mexico
Salix Investigational Site
Flat Rock, North Carolina
Salix Investigational Site
Winston-Salem, North Carolina
Salix Investigational Site
Cleveland, Ohio
Salix Investigational Site
Philadelphia, Pennsylvania
Salix Investigational Site
Austin, Texas
Salix Investigational Site
Houston, Texas
Salix Investigational Site
American Fork, Utah
Salix Investigational Site
Orem, Utah
Salix Investigational Site
Provo, Utah
Salix Investigational Site
Salt Lake City, Utah
Salix Investigational Site
Madison, Wisconsin
Salix Investigational Site
Darlinghurst, New South Wales, Australia
Salix Investigational Site
Coburg, Victoria, Australia
Salix Investigational Site
East Melbourne, Victoria, Australia
Salix Investigational Site
Leuven, Belgium
Salix Investigational Site
Liberdade, São Paulo, Brazil
Salix Investigational Site
São Paulo, São Paulo, Brazil
Salix Investigational Site
Edmonton, Alberta, Canada
Salix Investigational Site
Winnipeg, Manitoba, Canada
Salix Investigational Site
Hamilton, Ontario, Canada
Salix Investigational Site
Montreal, Quebec, Canada
Salix Investigational Site
Montreal, Quebec, Canada
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.